Literature DB >> 3764357

Quality of thought disorder in differential diagnosis.

P S Holzman, M E Shenton, M R Solovay.   

Abstract

The authors used a reliable scale to assess quantity and quality of thought disorder in manic, schizophrenic, schizoaffective manic, and schizoaffective depressed patients. High levels of thought disorder occurred in all psychotic groups except in the schizoaffective depressed group. Manic patients produced thought disorders that revealed both prominent combinatory thinking and intrusions of irrelevant ideas into the stream of discourse, usually with flippancy and humor. The thinking of schizophrenic patients was confused and fluid, and usually peppered with many idiosyncratic and peculiar words and phrases. Although schizoaffective manic patients resembled manics in their tendency to show combinatory thinking, their productions lacked the jocularity of the manics. The schizoaffective manic patients more strongly resembled the schizophrenic patients in their production of idiosyncratic verbalizations and in confused thinking. Schizoaffective depressed patients showed a strikingly constricted output, but produced a few noteworthy absurd responses, and in that respect resembled the schizophrenic patients. The authors suggest that quality of thought disorder differs in schizophrenia and in mania, and that the thought disorder of schizoaffective conditions resembles that of schizophrenia.

Entities:  

Mesh:

Year:  1986        PMID: 3764357     DOI: 10.1093/schbul/12.3.360

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  15 in total

1.  Exploring boundaries of schizophrenia: a comparison of ICD-10 with other diagnostic systems in first-admitted patients.

Authors:  Lennart Jansson; Peter Handest; Jan Nielsen; Ditte Sæbye; Josef Parnas
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

2.  Rorschach measures of cognition relate to everyday and social functioning in schizophrenia.

Authors:  Raeanne C Moore; Donald J Viglione; Irwin S Rosenfarb; Thomas L Patterson; Brent T Mausbach
Journal:  Psychol Assess       Date:  2012-11-12

Review 3.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

4.  A hierarchical finite mixture model that accommodates zero-inflated counts, non-independence, and heterogeneity.

Authors:  Charity J Morgan; Mark F Lenzenweger; Donald B Rubin; Deborah L Levy
Journal:  Stat Med       Date:  2014-01-20       Impact factor: 2.373

5.  Brain/behavior Asymmetry in Schizophrenia: A MEG Study of Cross-modal Semantic Priming.

Authors:  Karen Froud; Debra Titone; Alec Marantz; Deborah L Levy
Journal:  J Neurolinguistics       Date:  2010-05-01       Impact factor: 1.710

6.  Automatic semantic priming abnormalities in schizophrenia.

Authors:  Daniel H Mathalon; Brian J Roach; Judith M Ford
Journal:  Int J Psychophysiol       Date:  2009-12-06       Impact factor: 2.997

7.  Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls.

Authors:  Charity J Morgan; Michael J Coleman; Ayse Ulgen; Lenore Boling; Jonathan O Cole; Frederick V Johnson; Jan Lerbinger; J Alexander Bodkin; Philip S Holzman; Deborah L Levy
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

8.  Thought disorder in offspring of schizophrenic parents: findings from the New York High-Risk Project.

Authors:  Diane C Gooding; Michael J Coleman; Simone A Roberts; Martha E Shenton; Deborah L Levy; L Erlenmeyer-Kimling
Journal:  Schizophr Bull       Date:  2010-06-16       Impact factor: 9.306

Review 9.  Issues in the analysis of psychotic speech.

Authors:  S Swartz
Journal:  J Psycholinguist Res       Date:  1994-01

10.  ERP abnormalities during semantic processing in schizophrenia.

Authors:  J Adams; S F Faux; P G Nestor; M Shenton; B Marcy; S Smith; R W McCarley
Journal:  Schizophr Res       Date:  1993-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.